Aberrant O-GlcNAcylation disrupts GNE enzyme activity in GNE myopathy


    loading  Checking for direct PDF access through Ovid

Abstract

UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) is the key enzyme for the biosynthesis of sialic acids. Sialic acids are terminal monosaccharides of glycoconjugates and gangliosides, which have an essential influence on various cell interactions. The sialylation of proteins varies during development, aging, and pathogenesis of degenerative diseases such as Morbus Alzheimer, diabetes mellitus type II, or myopathies. Mutation of methionine 743 in the GNE leads to a 30% reduction of the enzyme activity and is responsible for an aggressive form of GNE myopathy. GNE myopathy or hereditary inclusion body myopathy (HIBM) is an age-dependent muscular dystrophy. Here, we analyzed the impact of the exchange of methionine to threonine at position 743 which introduces an additional potential phosphorylation/O-GlcNAcylation site. We found increased O-GlcNAcylation of the M743T variant compared to the wild-type GNE. In addition, removal of the O-GlcNAc of the M743T variant resulted in an increased activity comparable to activity of the wild-type GNE. Furthermore, the half-life of the M743T variant is two times longer than for the wild-type GNE protein. This study provides that the balance of phosphorylation and O-GlcNAcylation is decisive involved in efficiency and regulation of GNE.O-GlcNAcylation influences the stability, solubility, and enzyme activity of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE). The M743T variant of GNE, which is associated with an aggressive form of GNE myopathy, possesses reduced GNE activity. The Met-Thr substitution at position 743 introduces an additional potential phosphorylation/O-GlcNAcylation site and we found that removal of O-GlcNAc on the M743T variant restores GNE activity.

    loading  Loading Related Articles